Tenet 10-Q Details Q3 Net Income of $1.0B and $3.5B Nine-Month Operating Cash Flow
THC sits 72% above its 52-week low of $157.58 on elevated volume (2.0× avg).
Summary
Tenet's Q3 10-Q shows $1,000 million of net income to common ($12.41 diluted) and $3.507 billion of nine-month operating cash flow, with $646 million of quarterly revenue coming from the CHI contract termination. Buybacks totaled $1.615 billion year-to-date with $1.875 billion still authorized.
Key Events · Earnings and Guidance · THC
-
Q3 Net Income to Common $1.0B
Net income available to common shareholders was $1,000 million, or $12.41 diluted, versus $342 million and $3.86 a year earlier.
-
CHI Termination Adds $646M Revenue
Revenue from contract termination was $646 million in Q3 and $1,472 million for nine months, including a $233 million catch-up as the Conifer transition moved up to October 30, 2026.
-
Operating Cash Flow $3.507B
Nine-month operating cash flow rose to $3.507 billion from $2.809 billion, helped by $540 million of CHI termination payments received.
-
Buybacks $1.615B, $1.875B Left
Year-to-date repurchases cost $1.615 billion, leaving $1.875 billion available under the program at September 30, 2026.
Analysis · THC · Industrial Applications And Services
The headline numbers were already out this morning, but the 10-Q is where the quality of the quarter shows. Net income available to common shareholders was $1,000 million, or $12.41 diluted, against $342 million a year ago, and $646 million of the quarter's revenue came from the CHI/Conifer contract termination rather than operations. Operating cash flow of $3.507 billion for nine months funded $1.615 billion of buybacks and left $1.875 billion of repurchase authorization, with cash at $2.674 billion against $13.243 billion of debt. The one soft spot is payer mix: charity and uninsured admissions rose 26.0% and uninsured patient costs jumped to $144 million from $99 million.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, THC was trading at $270.57 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $21.8B. The 52-week trading range was $157.58 to $283.05. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.